Acarix Investor Relations Material
Latest events
Q4 2024
Acarix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Acarix
Access all reports
Acarix AB is a Swedish medical technology company specializing in diagnostic solutions for coronary artery disease (CAD). Its flagship product, the CADScor System, uses sensitive acoustics and advanced algorithms to assess coronary blood flow, providing a rapid, non-invasive method for ruling out CAD in patients experiencing chest pain. The system is designed for use in clinical settings by healthcare professionals to help streamline the diagnosis process. The company is headquartered in Malmö, Sweden, and its shares are traded on the Nasdaq Stockholm.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ACARIX
Country
🇸🇪 Sweden